Takeda to import and distribute 50 million doses of Moderna’s COVID-19 vaccine in Japan
OSAKA: Takeda Pharmaceutical Company Limited will import and distribute 50 million doses of Moderna’s COVID-19 vaccine candidate, mRNA-1273, starting in the first half of 2021, pending licensure in Japan, a news release said. This effort is part of a three-way…